Life Scienceshttps://www.jonesday.com/en/rss/practices/life-sciencesLife Sciences - Jones Dayen{92FC45E3-572F-4F87-A32C-FEC1EE30AD1C}https://www.jonesday.com/en/news/2024/06/chambers-usa-2024-ranks-leading-jones-day-practices-and-lawyersAwards & RankingsFirm NewsChambers USA 2024 ranks leading Jones Day practices and lawyersFri, 07 Jun 2024 00:00:00 -0500{192EF65D-9DDC-4D50-8038-D18622F7B5E6}https://www.jonesday.com/en/insights/2024/06/apter-v-hhs--you-are-not-a-horse-and-fda-is-not-a-physician-fdli-top-food--drug-cases-2023Reprint<i>Apter v. HHS</i>: You are not a horse, and FDA is not a physician (<i>FDLI Top Food & Drug Cases</i>, 2023)Thu, 06 Jun 2024 00:00:00 -0500{40DF4DD0-F635-4293-866B-C782073091CF}https://www.jonesday.com/en/news/2024/06/jones-day-at-top-of-bti-allstar-list-for-third-straight-yearAwards & RankingsFirm NewsJones Day at top of BTI All-Star list for third straight yearTue, 04 Jun 2024 00:00:00 -0500{A0E0774A-656F-45C9-98F6-99C93BD040DD}https://www.jonesday.com/en/insights/2024/05/mandatory-disclosure-on-forever-chemicalsAlertMandatory Disclosure on "Forever Chemicals," PFAS, in One State Propagates Consumer Class Action in AnotherWed, 29 May 2024 00:00:00 -0500{89E16B87-6A27-4A38-8EC1-7E6352F819DC}https://www.jonesday.com/en/insights/2024/05/nih-seeks-comments-on-patient-access-plan-requirements-in-patent-license-agreementsCommentaryNIH Seeks Comments on Patient Access Plan Requirements in Patent License AgreementsTue, 28 May 2024 00:00:00 -0500{A8AA9920-D689-48FC-B290-DB46D15E8CC8}https://www.jonesday.com/en/insights/2024/05/canadian-drug-importation-may-undermine-ip-protectionCommentaryCanadian Drug Importation May Undermine Intellectual Property ProtectionThu, 23 May 2024 00:00:00 -0500{04AE99AF-6708-4DEF-9A96-9E3B0CE9EB7F}https://www.jonesday.com/en/insights/2024/05/eu-emergency-response-update-key-policy-regulatory-developments-no-113NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 113Fri, 17 May 2024 00:00:00 -0500{F0047633-EEFC-45C5-BC8D-B9371257FE47}https://www.jonesday.com/en/news/2024/05/laura-laemmleweidenfeld-appointed-to-the-board-of-directors-of-the-american-health-law-associationFirm NewsDiversityLaura Laemmle-Weidenfeld appointed to the Board of Directors of the American Health Law AssociationWed, 08 May 2024 00:00:00 -0500{1AF448C8-3128-4BBD-9E9D-2DAFBEBC6422}https://www.jonesday.com/en/insights/2024/04/ftc-weighs-in-on-orange-book-listing-of-drugdevice-patentsCommentaryFTC Weighs In on Orange Book Listing of Drug-Device PatentsTue, 30 Apr 2024 00:00:00 -0500{1B0BDB5E-0FA8-4314-B040-CA55849D0403}https://www.jonesday.com/en/insights/2024/04/fda-proposes-updated-guidance-concerning-cybersecurity-of-medical-devicesAlertFDA Proposes Updated Guidance Concerning Cybersecurity of Medical DevicesWed, 24 Apr 2024 00:00:00 -0500{D75F62F5-623B-40EE-9814-85D3FAA49833}https://www.jonesday.com/en/insights/2024/04/2023-false-claims-act-enforcement-in-health-care-and-life-sciences-part-iiWhite Paper2023 False Claims Act Enforcement in Health Care and Life Sciences, Part IIFri, 05 Apr 2024 00:00:00 -0500{72B0388E-004D-4184-821B-D19280505775}https://www.jonesday.com/en/insights/2024/04/second-circuit-reinforces-antikickback-statutes-demanding-willfulness-standardCommentarySecond Circuit Reinforces Anti-Kickback Statute's Demanding Willfulness StandardFri, 05 Apr 2024 00:00:00 -0500{7ADB18B0-B0BD-48B1-BC15-479262A9E257}https://www.jonesday.com/en/insights/2024/04/california-health-care-providers-to-face-greater-headwinds-with-proposed-cost-targetsCommentaryCalifornia Health Care Providers to Face Greater Headwinds as State Implements Health Care Cost TargetsWed, 03 Apr 2024 00:00:00 -0500{84F62365-0C26-4A16-9D7A-20EEC11FBC98}https://www.jonesday.com/en/insights/2024/04/new-state-health-privacy-lawsmoving-beyond-hipaa-and-recasting-consumer-health-data-rightsAlertNew State Health Privacy Laws—Moving Beyond HIPAA and Recasting Consumer Health Data Rights?Mon, 01 Apr 2024 00:00:00 -0500{C352D430-01CD-4762-8277-8267B27A8FF2}https://www.jonesday.com/en/insights/2024/03/2023-false-claims-act-enforcement-in-hcls-part-iWhite Paper2023 False Claims Act Enforcement in Health Care and Life Sciences, Part IFri, 29 Mar 2024 00:00:00 -0500{B2AE5E53-1840-45B8-ADEB-039A53F1EEA8}https://www.jonesday.com/en/insights/2024/03/eu-emergency-response-update--key-policy--regulatory-developments-no-112NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 112Fri, 29 Mar 2024 00:00:00 -0500{C62F11DA-9AD8-4FBD-9E9E-1A7A348F166B}https://www.jonesday.com/en/insights/2024/03/fdas-final-device-manufacturing-rulenot-quite-harmonious-with-status-quoAlertJones Day PublicationsFDA's Final Device Manufacturing Rule—Not Quite Harmonious With Status Quo Wed, 20 Mar 2024 00:00:00 -0500{503502B2-1EA8-46CA-BC95-D56C4D05332C}https://www.jonesday.com/en/insights/2024/03/vital-signs-digital-health-law-update--winter-2024NewslettersVital Signs: Digital Health Law Update | Winter 2024Wed, 13 Mar 2024 00:00:00 -0500{D2C215DE-C80F-43CB-81B6-770E3C12282A}https://www.jonesday.com/en/insights/2024/03/federal-agencies-launch-joint-inquiry-into-private-investment-in-health-careAlertFederal Agencies Launch Joint Inquiry Into Private Investment in Health CareMon, 11 Mar 2024 00:00:00 -0500{012076D7-A723-412A-A496-B6539130DDAD}https://www.jonesday.com/en/news/2024/03/jones-day-and-10-lawyers-recognized-in-jd-supras-2024-readers-choice-awardsFirm NewsJones Day and 10 lawyers recognized in JD Supra's 2024 Readers' Choice AwardsMon, 11 Mar 2024 00:00:00 -0500{A255FD65-6081-42C5-A82B-F91DECD973A7}https://www.jonesday.com/en/news/2024/03/chambers-global-ranks-leading-jones-day-practices-and-lawyersAwards & RankingsFirm News Chambers Global ranks leading Jones Day practices and lawyersFri, 08 Mar 2024 00:00:00 -0600{21053768-B995-4337-BAA4-A2EC75766758}https://www.jonesday.com/en/insights/2024/03/the-epo-sets-timeline-for-new-accelerated-opposition-practiceAlertFinish in Eight Months: The EPO Sets Timeline for New Accelerated Opposition PracticeTue, 05 Mar 2024 00:00:00 -0600{C6B2B183-75BF-480E-9709-3020FD88CAAD}https://www.jonesday.com/en/insights/2024/03/new-yorks-recipe-for-food-marketing-next-course-of-restrictive-state-actionsCommentaryNew York's Recipe for Food Marketing: Next Course of Restrictive State Actions?Tue, 05 Mar 2024 00:00:00 -0600{2C7C2B4F-9BFD-4464-83EB-E3F910A92CFC}https://www.jonesday.com/en/insights/2024/03/fiduciaries-beware_employer-health-plan-under-fireAlertFiduciaries Beware: Employer Health Plan Under Fire for Alleged Prescription Drug MismanagementFri, 01 Mar 2024 00:00:00 -0600{77A59019-DF86-4418-B3BB-6A49387C3580}https://www.jonesday.com/en/insights/2024/02/doj-announces-recordbreaking-year-for-false-claims-act-settlements-and-judgmentsAlertDOJ Announces Record-Breaking Year for False Claims Act Settlements and JudgmentsWed, 28 Feb 2024 00:00:00 -0600{1A712610-F1A5-43A9-ABB4-47EBC2D5BFED}https://www.jonesday.com/en/insights/2024/02/fda-on-board-with-continuing-remote-inspectionsAlertFDA on Board With Continuing Remote InspectionsWed, 21 Feb 2024 00:00:00 -0600{A0BC7CB6-CF1C-4B08-A606-B9CD5C582DE8}https://www.jonesday.com/en/insights/2024/02/ban-on-eu-patents-for-plants-engineered-by-new-genomic-techniques-nears-realityAlertBan on European Patents for Plants Engineered by "New Genomic Techniques" Nearing RealityMon, 19 Feb 2024 00:00:00 -0600{169C72E1-BBC9-461C-BBE8-B6CB1468F68C}https://www.jonesday.com/en/insights/2024/02/hhs-releases-cybersecurity-performance-goals-for-the-health-care-sectorAlertHHS Releases Cybersecurity Performance Goals to Enhance Cybersecurity for Health Care and Public Health SectorsThu, 15 Feb 2024 00:00:00 -0600{1491BA85-413F-43C3-8F74-1D22B0A40FFA}https://www.jonesday.com/en/insights/2024/02/american-hospital-association-aha--jones-day-human-trafficking-interviewVideoAmerican Hospital Association (AHA) & Jones Day Human Trafficking InterviewWed, 14 Feb 2024 00:00:00 -0600{E2129026-2B75-4F5E-ADA7-2AB52A145617}https://www.jonesday.com/en/news/2024/01/chambers-greater-china-ranks-leading-jones-day-practices-and-lawyersAwards & RankingsFirm NewsChambers Greater China ranks leading Jones Day practices and lawyersThu, 25 Jan 2024 00:00:00 -0600{C1096331-6290-40B7-BE27-AC868D41096F}https://www.jonesday.com/en/insights/2024/01/fda-final-rule-irb-waiver-of-informed-consent-for-minimalrisk-investigationsAlertFDA Final Rule: IRB Waiver of Informed Consent for Minimal-Risk InvestigationsFri, 19 Jan 2024 00:00:00 -0600{BB7190D0-1829-4842-BE0B-3864E5751A04}https://www.jonesday.com/en/insights/2024/01/hhs-announces-upcoming-federal-strategies-to-enhance-cybersecurity-for-health-care-and-public-health-sectorsAlertHHS Announces Upcoming Federal Strategies to Enhance Cybersecurity for Health Care and Public Health SectorsTue, 09 Jan 2024 00:00:00 -0600{DACCEBAA-E9F9-4028-B633-EB2D3F10F3B1}https://www.jonesday.com/en/insights/2024/01/eu-releases-data-act-to-facilitate-access-and-use-of-dataAlertEU Releases Data Act to Facilitate Access and Use of DataMon, 08 Jan 2024 00:00:00 -0600{B9A22BE8-C173-4281-96B2-02661D6A27B1}https://www.jonesday.com/en/news/2024/01/claire-castles-again-named-to-los-angeles-business-journals-list-of-leaders-of-influence-thriving-in-their-fortiesAwards & RankingsFirm NewsDiversityClaire Castles again named to Los Angeles Business Journal's list of "Leaders of Influence: Thriving in Their Forties"Thu, 04 Jan 2024 00:00:00 -0600{E3100880-B25D-493F-97DD-721303C2EE94}https://www.jonesday.com/en/insights/2024/02/eu-emergency-response-update--key-policy--regulatory-developments-no-111NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 111Fri, 29 Dec 2023 00:00:00 -0600{9A1180AF-59E4-4426-A76F-CF1357B618FD}https://www.jonesday.com/en/insights/2024/01/eu-emergency-response-update--key-policy--regulatory-developments-no-110NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 110Thu, 28 Dec 2023 00:00:00 -0600{312E63A5-6DAF-4776-B711-D22D739255FD}https://www.jonesday.com/en/insights/2023/12/fdas-recent-litigation-records-are-strong-but-imperfect-law360ReprintFDA's Recent Litigation Records Are Strong, But Imperfect (Law360)Thu, 21 Dec 2023 00:00:00 -0600{3A1C91A3-C423-4D76-83FF-AA0E445E2D10}https://www.jonesday.com/en/insights/2023/12/federal-agencies-seeking-patent-seizure-authority-through-draft-nist-guidanceCommentaryFederal Agencies Seeking Patent Seizure Authority Through Draft NIST GuidanceTue, 19 Dec 2023 00:00:00 -0600{A1A9271E-08F4-401E-8AD4-04B84560D557}https://www.jonesday.com/en/insights/2023/12/eu-emergency-response-update--key-policy--regulatory-developments-no-109NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 109Wed, 13 Dec 2023 00:00:00 -0600{5378295E-89B0-4730-A10F-7C40BED8B0FF}https://www.jonesday.com/en/news/2023/12/jones-day-names-51-new-partnersFirm NewsJones Day names 51 new partnersTue, 12 Dec 2023 00:00:00 -0600{CC58D3C0-AA24-48CD-B597-8369EE6066B0}https://www.jonesday.com/en/insights/2023/12/hhs-enters-into-firstever-ransomware-resolution-agreement-and-corrective-action-planAlertHHS Enters Into First-Ever Ransomware Resolution Agreement and Corrective Action PlanMon, 04 Dec 2023 00:00:00 -0600{7C54A41D-6606-4E60-AC93-62A0B6FA9789}https://www.jonesday.com/en/news/2023/11/jones-day-named-law-firm-of-the-year-in-antitrust-litigation-among-296-rankings-in-2024-best-law-firmsAwards & RankingsFirm NewsJones Day named "Law Firm of the Year" in Antitrust Litigation among 296 rankings in 2024 Best Law Firms®Thu, 30 Nov 2023 00:00:00 -0600{C24467F7-4C85-4DF7-85FA-BE33F63E01D5}https://www.jonesday.com/en/insights/2023/11/ny-proposes-cybersecurity-rules-for-hospitalsAlertNew York Governor Proposes Stringent Cybersecurity Regulations for HospitalsThu, 30 Nov 2023 00:00:00 -0600{61371930-B0D4-47B2-9F31-54AD1420D98B}https://www.jonesday.com/en/insights/2023/11/hhsoig-issues-general-compliance-program-guidanceCommentaryHHS-OIG Issues Long-Anticipated General Compliance Program Guidance for All Health Care StakeholdersWed, 29 Nov 2023 00:00:00 -0600{BA113E2A-AE3B-4383-A8E9-9087F8517C87}https://www.jonesday.com/en/insights/2023/11/fda-issues-revised-offlabel-communications-guidanceAlertFDA Issues Revised Off-Label Communications GuidanceWed, 22 Nov 2023 00:00:00 -0600{ABF24BAC-0DC5-42AE-8141-F3922A8EBF01}https://www.jonesday.com/en/insights/2023/11/vital-signs-digital-health-law-update--fall-2023NewslettersVital Signs: Digital Health Law Update | Fall 2023Tue, 21 Nov 2023 00:00:00 -0600{709D1A25-9CCF-4332-AE17-5C232A6DB31A}https://www.jonesday.com/en/insights/2023/11/eu-emergency-response-update--key-policy--regulatory-developments-no-108NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 108Fri, 17 Nov 2023 00:00:00 -0600{0291331A-AA08-4AD4-9E71-EE2B0C9E97A1}https://www.jonesday.com/en/news/2023/11/jones-days-ann-hollenbeck-named-among-crains-detroit-business-notable-leaders-in-dei-for-2023Awards & RankingsFirm NewsDiversityJones Day's Ann Hollenbeck named among Crain's Detroit Business' "Notable Leaders in DEI" for 2023Tue, 14 Nov 2023 00:00:00 -0600{8C191357-0B82-4948-9B46-26D97D293F54}https://www.jonesday.com/en/insights/2023/11/michigan-may-repeal-pharma-immunity-in-tort-suitsAlertMichigan Senate Votes to Repeal Pharmaceutical Immunity From Product Liability SuitsWed, 08 Nov 2023 00:00:00 -0600{F4AE5CC7-8A9C-4A37-9605-5A7DDED58C12}https://www.jonesday.com/en/insights/2023/11/reversal-of-burden-of-proofCommentaryReversal of Burden of Proof Under Proposal for a New EU Product Liability DirectiveTue, 07 Nov 2023 00:00:00 -0600{A25EE52E-DDFF-4F3B-8C2D-840D60A4AA7C}https://www.jonesday.com/en/insights/2023/10/fda-proposes-rule-for-laboratory-developed-testsAlertFDA Announces Proposed Rule Regarding Laboratory Developed TestsMon, 30 Oct 2023 00:00:00 -0500{7F33817D-0918-4A1A-87C9-CBB38AF13433}https://www.jonesday.com/en/insights/2023/10/eu-emergency-response-update--key-policy--regulatory-developments-no-107NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 107Mon, 23 Oct 2023 00:00:00 -0500{9CC96B59-E7FB-41CE-A5B9-6D679A99A4DA}https://www.jonesday.com/en/insights/2023/10/california-becomes-the-first-state-to-ban-four-common-food-additivesAlertCalifornia Becomes the First State to Ban Four Common Food AdditivesThu, 19 Oct 2023 00:00:00 -0500{175E812E-BA50-4110-B3E2-BCCE8734D422}https://www.jonesday.com/en/insights/2023/10/jones-day-talks-the-evolution-of-corporate-compliance-programs--key-issues-for-multinational-companiesPodcastJONES DAY TALKS® - The Evolution of Corporate Compliance Programs: Key Issues for Multinational CompaniesTue, 03 Oct 2023 00:00:00 -0500{788F0FEB-5E64-4D5F-B760-3BD62DB317D7}https://www.jonesday.com/en/insights/2023/10/eu-emergency-response-update--key-policy--regulatory-developments-no-106NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 106Mon, 02 Oct 2023 00:00:00 -0500{536716A6-A16F-45A3-9B49-88A9AB0137C5}https://www.jonesday.com/en/insights/2023/09/fda-delays-certain-drug-supply-chain-requirementsAlertFDA Announces Delayed Enforcement of Looming Supply Chain Requirements for Drugs Until 2024Mon, 25 Sep 2023 00:00:00 -0500{F684D5E5-BA08-4620-A238-048CA49A39C2}https://www.jonesday.com/en/insights/2023/09/eu-emergency-response-update--key-policy--regulatory-developments-no-105NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 105Fri, 15 Sep 2023 00:00:00 -0500{161D07DF-F2C9-4E21-8397-174BB8D13826}https://www.jonesday.com/en/insights/2023/09/vital-signs-digital-health-law-update-summer-2023NewslettersVital Signs Digital Health Law Update | Summer 2023Thu, 07 Sep 2023 00:00:00 -0500{3C850934-92A7-4839-8F69-205EB8707090}https://www.jonesday.com/en/insights/2023/08/industry-anticipates-impending-fda-proposed-regulation-addressing-laboratory-developed-testsAlertIndustry Anticipates Impending FDA Proposed Regulation Addressing Laboratory Developed TestsWed, 30 Aug 2023 00:00:00 -0500{35561640-7023-43EE-9CB9-45474621256E}https://www.jonesday.com/en/insights/2023/08/the-cfpb-is-scrutinizing-health-care-financingWhite PaperMedical Payment Products and Health Care Pricing Practices Draw CFPB AttentionWed, 30 Aug 2023 00:00:00 -0500{089196BE-80F9-470D-9EF9-8F31D01C47BB}https://www.jonesday.com/en/insights/2023/08/clarifying-cosmetics-reform-fda-issues-draft-guidance-on-registration-and-product-listingsAlertClarifying Cosmetics Reform: FDA Issues Draft Guidance on Registration and Product ListingsFri, 18 Aug 2023 00:00:00 -0500{E1021326-21D1-44D2-98EB-F47BE96F8D11}https://www.jonesday.com/en/news/2023/08/the-best-lawyers-in-america-2024-names-395-jones-day-lawyers-across-69-practice-areasAwards & RankingsFirm NewsThe Best Lawyers in America® 2024 names 395 Jones Day lawyers across 69 practice areasFri, 18 Aug 2023 00:00:00 -0500{B38AE7B9-FB8F-4015-AEF0-5A91E887D293}https://www.jonesday.com/en/insights/2023/08/eu-emergency-response-update--key-policy--regulatory-developments-no-104NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 104Wed, 09 Aug 2023 00:00:00 -0500{83F67E73-B399-49A2-B004-97914C936E1F}https://www.jonesday.com/en/insights/2023/08/congress-aims-to-improve-organ-transplant-systemAlertCongress Authorizes Competitive Multivendor Contracts in U.S. Organ Transplant SystemTue, 08 Aug 2023 00:00:00 -0500{E41EC9DA-9A92-4D86-93CA-FFA89B7BCFC5}https://www.jonesday.com/en/insights/2023/07/eu-emergency-response-update--key-policy--regulatory-developments-no-103NewslettersEU Emergency Response Update – Key Policy & Regulatory Developments No. 103Wed, 19 Jul 2023 00:00:00 -0500{F5A6DAFB-868B-4821-B4C2-DF396875DF52}https://www.jonesday.com/en/news/2023/07/legal-500-united-states-2023-ranks-leading-jones-day-practices-and-lawyersAwards & RankingsFirm NewsLegal 500 United States 2023 ranks leading Jones Day practices and lawyersThu, 06 Jul 2023 00:00:00 -0500{92E1B826-7C0B-4CA9-AFA9-EF6E69ECF176}https://www.jonesday.com/en/insights/2023/06/hhsoig-issues-faqs-related-to-pharmacy-benefit-manager-arrangementsAlertHHS-OIG Issues FAQ Guidance Related to Pharmacy Benefit Manager ArrangementsThu, 29 Jun 2023 00:00:00 -0500{291AC731-C0CF-4D9E-B50F-F03FF07757DC}https://www.jonesday.com/en/insights/2023/06/ftc-public-comment-request-signals-continued-increase-in-state-ags-enforcement-effortsAlert FTC Public Comment Request Signals Continued Increase in State AGs Enforcement EffortsThu, 22 Jun 2023 00:00:00 -0500{D074CBBD-1139-4C2D-8A60-B0EF15D3BCAA}https://www.jonesday.com/en/insights/2023/06/the-us-supreme-court-affirms-the-governments-authority-to-dismiss-fca-qui-tam-cases-after-declining-to-interveneAlertThe U.S. Supreme Court Affirms the Government's Authority to Dismiss FCA Qui Tam Cases After Declining to InterveneTue, 20 Jun 2023 00:00:00 -0500